[Diabetic patients after myocardial infarction].
Diabetes mellitus is not just another risk factor for cardiovascular events; it per se defines maximal risk for target organ damage including the cardiovascular system. Diabetes is one of the main drivers in the race towards a higher incidence in cardiovascular disease worldwide. In addition, it is also one of the often unrecognized predecessors of myocardial infarction and sudden cardiac death. About three quarters of patients post-MI show impaired glucose tolerance or full blown diabetes. The MONICA/KORA data have shown that the higher risk for mortality and morbidity in diabetics is maintained past the first event. However, the STENO-2 trial has shown that consequently managing diabetes and concomitant cardiovascular risk factors can significantly reduce the risk for cardiovascular events in this high-risk group.
Tschöpe
D
D
Diabeteszentrums am Herz- und Diabeteszentrum Nordrhein-Westfalen, Universitätsklinik der Ruhr-Universität, Georgstrasse 11, 32545 Bad Oeynhausen, Germany.
D002986:Clinical Trials as Topic; D016757:Death, Sudden, Cardiac / Q000209:etiology / Q000517:prevention & control; D003925:Diabetic Angiopathies / Q000209:etiology / Q000401:mortality / Q000534:rehabilitation*; D005500:Follow-Up Studies; D006801:Humans; D009203:Myocardial Infarction / Q000209:etiology / Q000401:mortality / Q000534:rehabilitation*; D012307:Risk Factors; D055502:Secondary Prevention; D016896:Treatment Outcome